Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Total 13F shares
-
3,181,141
-
Share change
-
+738,363
-
Total reported value
-
$20,606,078
-
Put/Call ratio
-
114%
-
Price per share
-
$6.50
-
Number of holders
-
42
-
Value change
-
+$4,751,567
-
Number of buys
-
32
-
Number of sells
-
8
Institutional Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q4 2017
As of 31 Dec 2017,
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,181,141 shares.
The largest 10 holders included
Vanguard Group Inc, Skylands Capital, LLC, Manatuck Hill Partners, LLC, MILLENNIUM MANAGEMENT LLC, B. Riley Financial, Inc., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES & ASSOCIATES, PEAK6 Investments, L.P., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
41
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.